Camellia-derived flavonoids
By using enzyme treatment of erectin glycoside compounds in tea oil residues, skin protection compositions are prepared, which solves the problems of waste of plant-derived components and is inefficient, and achieves safe and efficient skin protection and regeneration effects.
JP2025019024APending Publication Date: 2025-02-06AMOREPACIFIC CORP
2 Cites 0 Cited by
Patent Information
- Application Number
- JP2024119555
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-06-28
- Filing Date
- 2024-07-25
- Publication Date
- 2025-02-06
AI Technical Summary
Technical Problem
Existing plant-derived skin protection ingredients use a large number of plant resources or are inefficient due to molecular structure and molecular weight, and are insecure and insufficient safety and effect.
Method used
Safe, low-side effects skin protection compositions are prepared by enzymatic treatment of lecitin glycoside compounds from tea oil residues, which specifically inhibit 3-inositide-dependent kinase 1 (PDK1) activity.
Benefits of technology
It achieves efficient skin protection effects, including inhibiting PDK1 activity, promoting skin regeneration and improving signs of aging, and enhancing skin barrier function.
✦ Generated by Eureka AI based on patent content.
Abstract
To provide a novel kaempferol compound obtained by enzymatically treating kaempferol saccharides extracted from Camellia oleifera seed cake, which is discarded after oil extraction from camellia seeds, and a skin protection composition containing the same that is safe for the human body.SOLUTION: An enzyme-treated kaempferol compound has an increased molecular weight as sugar is additionally linked to the precursor kaempferol saccharide, and can exhibit a skin protection effect.SELECTED DRAWING: Figure 5
Need to check novelty before this filing date? Find Prior Art